BeStock  
Stocks › Biotechnology › INCY

Incyte INCY

US equityMarket cap rank #509BiotechnologyCAR-T Therapy
$119.39 −$1.96 (-1.62%)
Market open · Oct 1, 11:50 am ET · After hours $121.35 0.00%
Open$120.47
Prev close$121.35
Day range$119.02 – $121.22
Volume525.5K
Market cap$24.20B
P/E (TTM)15.2
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$1.67B+37.7% YoY
Operating profit$700.39M+125.3% YoY
Net profit$585.61M+44.6% YoY
Diluted EPS$2.81+37.7% YoY
Free cash flow$495.25M+1,829.5% YoY
Operating cash flow$507.66M

Revenue, last 8 quarters

$1.1BSep '24$1.2BDec '24$1.1BMar '25$1.2BJun '25$1.4BSep '25$1.5BDec '25$1.3BMar '26$1.7BJun '26

Net profit, last 8 quarters

$106.5MSep '24$201.2MDec '24$158.2MMar '25$405.0MJun '25$424.2MSep '25$299.3MDec '25$303.3MMar '26$585.6MJun '26

Diluted EPS by quarter

0.54Sep '241.02Dec '240.80Mar '252.04Jun '252.11Sep '251.46Dec '251.47Mar '262.81Jun '26

Free cash flow by quarter

$293.2MSep '24$363.8MDec '24$262.9MMar '25$25.7MJun '25$519.6MSep '25$521.4MDec '25$354.2MMar '26$495.2MJun '26

Annual revenue

$2.7BFY20$3.0BFY21$3.4BFY22$3.7BFY23$4.2BFY24$5.1BFY25

Profitability & balance sheet

Gross margin92.6%
Operating margin31.6%
Net margin27.7%
Return on equity30.7%
Return on assets23.5%
Return on invested capital28.5%
Current ratio4.59
Liabilities / assets19.4%
Cash & investments$4.54B
Total debt$28.42M
Net cash (debt)$4.51B
Free cash flow / sales32.5%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $1.67B $1.27B $5.14B $1.51B $1.37B
Total Operating Revenue $1.67B $1.27B $5.14B $1.51B $1.37B
Cost of Revenue $105.00M $104.50M $372.10M $121.10M $99.00M
Gross Profit $1.57B $1.17B $4.77B $1.39B $1.27B
Operating Expense $868.65M $844.00M $3.43B $1.00B $835.68M
Selling and Admin Expenses $351.70M $328.10M $1.38B $390.40M $329.10M
-General & Admin Expense $351.70M $328.10M $1.38B $390.40M $329.10M
Research & Development $516.95M $515.90M $2.05B $611.37M $506.58M
Operating Profit $700.39M $324.17M $1.34B $383.96M $431.30M
Net Non-Operating Interest Income (Expense) $37.54M $33.12M $103.17M $30.17M $26.19M
Non-Operating Interest Income $38.12M $33.69M $105.60M $30.75M $26.78M
Non-Operating Interest Expense $582,000.00 $569,000.00 $2.43M $582,000.00 $592,000.00
Other Income (Expense) $13.58M -$13.68M $218.53M -$24.11M $24.81M
Gain on Sale of Security $9.81M $6.59M $21.31M $18.25M $8.56M
Special Income (Charges) -$2.50M -$23.05M $172.11M -$48.02M $12.20M
-Less:Restructuring and Mergern & Acquisition $2.50M -$168,000.00 -$6.13M -$28.26M -$12.20M
-Less:Write Off $0.00 $23.21M $76.28M – –
Other Non-Operating Income (Expenses) $6.28M $2.77M $25.11M $5.66M $4.04M
Pretax Profit $751.51M $343.60M $1.66B $389.94M $482.31M
Tax $165.91M $40.27M $377.80M $90.66M $58.14M
Net Profit $585.61M $303.33M $1.29B $299.28M $424.17M
Profit from Continuing Operations $585.61M $303.33M $1.29B $299.28M $424.17M
Net Income to Parent Company $585.61M $303.33M $1.29B $299.28M $424.17M
Net Income to Common Stockholders $585.61M $303.33M $1.29B $299.28M $424.17M
Basic EPS $2.92 $1.52 $6.59 $1.52 $2.17
Diluted EPS $2.81 $1.47 $6.41 $1.46 $2.11
-Less:Other Special Charges – – -$242.25M $0.00 –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $7.87B $7.34B $6.96B $6.96B $6.33B
Total Current Assets $6.03B $5.48B $5.02B $5.02B $4.28B
Cash and Cash Equivalents & Short-Term Investments $4.54B $4.02B $3.58B $3.58B $2.93B
-Cash and Cash Equivalents $3.98B $3.46B $3.10B $3.10B $2.46B
-Short Term Investments $553.37M $554.71M $482.79M $482.79M $474.81M
Receivables $1.13B $1.05B $1.02B $1.02B $895.89M
-Accounts Receivable $1.13B $1.05B $1.02B $1.02B $895.89M
Inventory $112.54M $115.62M $101.06M $101.06M $83.45M
Other Current Assets $253.09M $301.31M $317.83M $317.83M $368.73M
Total Non-Current Assets $1.85B $1.85B $1.93B $1.93B $2.05B
Net PPE $735.03M $746.84M $758.41M $758.41M $826.79M
-Gross PPE $1.14B $1.14B $1.13B $1.13B $1.19B
-Accumulated Depreciation -$403.91M -$389.00M -$375.07M -$375.07M -$360.60M
Investments and Advances $104.39M $54.58M $47.99M $47.99M $21.87M
-Long Term Equity Investment $104.39M $54.58M $47.99M $47.99M $21.87M
Goodwill and Other Intangible Assets $236.20M $243.16M $250.13M $250.13M $275.01M
-Goodwill $133.00M $133.00M $133.00M $133.00M $155.59M
-Other Intangible Assets $103.20M $110.16M $117.13M $117.13M $119.42M
Non-Current Deferred Assets $336.86M $452.52M $515.29M $515.29M $528.14M
Other Non-Current Assets $433.60M $357.75M $362.25M $362.25M $400.66M
Total Liabilities $1.53B $1.72B $1.79B $1.79B $1.68B
Total Current Liabilities $1.31B $1.49B $1.52B $1.52B $1.34B
Payables $252.64M $234.56M $214.69M $214.69M $177.44M
-Accounts Payable $250.40M $228.62M $209.94M $209.94M $171.93M
-Total Tax Payable $2.24M $5.93M $4.76M $4.76M $5.51M
Current Accrued Expenses $267.51M $279.92M $287.86M $287.86M $243.53M
Short-Term Debt and Capital Lease Obligation $9.85M $10.02M $10.21M $10.21M $10.39M
-Current Capital Lease Obligation $9.85M $10.02M $10.21M $10.21M $10.39M
Current Provisions $526.44M $722.41M $642.47M $642.47M $599.86M
Other Current Liabilities $107.35M $117.83M $131.87M $131.87M $139.26M
Total Non-Current Liabilities $216.12M $226.62M $275.33M $275.33M $340.43M
Long Term Debt and Capital Lease Obligation $28.42M $29.41M $30.20M $30.20M $30.88M
-Long Term Capital Lease Obligation $28.42M $29.41M $30.20M $30.20M $30.88M
Other Non-Current Liabilities $187.70M $197.20M $245.13M $245.13M $309.55M
Total Equity $6.34B $5.62B $5.17B $5.17B $4.65B
Stockholders' Equity $6.34B $5.62B $5.17B $5.17B $4.65B
Capital Stock $201,000.00 $200,000.00 $198,000.00 $198,000.00 $196,000.00
-Common Stock $201,000.00 $200,000.00 $198,000.00 $198,000.00 $196,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $5.22B $5.08B $4.93B $4.93B $4.72B
Retained Earnings $1.10B $517.10M $213.77M $213.77M -$85.51M
Gains/Losses Not Affecting Retained Earnings $19.72M $22.31M $25.46M $25.46M $14.56M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $507.66M $369.35M $1.41B $543.30M $559.39M
Net cash flow from continuing operations $507.66M $369.35M $1.41B $543.30M $559.39M
Net Income from Continuing Operations $585.61M $303.33M $1.29B $299.28M $424.17M
Depreciation & Depletion & Amortization $26.48M $23.80M $93.29M $23.98M $24.02M
Deferred Tax $115.62M $63.42M $247.69M $13.50M $124.12M
Other Non-Cash Items $4.11M $12.60M $8.73M -$16.85M -$5.54M
Change in Working Capital -$281.61M -$91.34M -$527.16M $103.20M -$60.42M
-Change in Receivables -$73.80M -$27.03M -$170.77M -$128.50M -$53.00M
-Change in Inventory -$11.88M -$12.23M -$58.51M -$4.86M -$5.56M
-Change in Prepaid Assets -$14.04M $9.19M -$156.24M $65.04M -$72.84M
-Change in Payables and Accrued Expense -$181.89M -$61.28M -$141.64M $171.52M $70.97M
Net cash flow from investing -$51.79M -$88.20M -$102.61M -$37.42M -$47.42M
Net Cash Flow from Continuing Investing Activities -$51.79M -$88.20M -$102.61M -$37.42M -$47.42M
Capital Expenditure -$12.41M -$10.20M -$58.87M -$21.88M -$14.75M
Net Intangibles Purchase and Sale $0.00 -$5.00M -$25.00M $0.00 -$25.00M
Net Investment Purchase and Sale -$39.38M -$73.00M -$18.74M -$15.54M -$7.67M
Financing Cash Flow $65.46M $84.82M $101.04M $137.74M -$12.78M
Net Cash Flow from Continuing Financing Activities $65.46M $84.82M $101.04M $137.74M -$12.78M
Net Issuance Payments Of Debt -$1.16M -$1.18M -$4.54M -$1.16M -$1.14M
Proceeds from Stock Option Exercised $75.15M $97.93M $221.76M $160.21M $43.43M
Net Other Financing Charges -$8.53M -$11.92M -$116.18M -$21.31M -$55.07M
Ending Cash Balance $3.98B $3.46B $3.10B $3.10B $2.46B
Net Change in Cash $521.33M $365.97M $1.41B $643.62M $499.20M
Beginning Cash Balance $3.46B $3.10B $1.69B $2.46B $1.96B
Effect of Exchange Rate Changes -$84,000.00 -$2.69M -$1.71M -$801,000.00 $841,000.00
Free Cash Flow $495.25M $354.15M $1.33B $521.42M $519.64M
Gain/Loss from Continuing Operations – – -$21.31M -$18.25M -$8.56M
Net Common Stock Issuance – – $0.00 $0.00 –

Discussion

No comments yet — be the first to weigh in on INCY.

Leave a comment

Scroll to Top